Drugs charges under the NDRC spotlight
CHINA'S top economic planner is to investigate 60 pharmaceutical companies, including several joint ventures with foreign firms, for excessive charges.
The National Development and Reform Commission will send teams to check wholesale prices and production costs at dozens of companies.
It said the companies include Sino-foreign joint ventures with Britain's GlaxoSmithKline, Germany's Boehringer-Ingelheim and global health care firm MSD.
The inquiry will also look at Chinese companies, among them industry leader Sinopharm Group and Jiangsu Hengrui Medicine.
Police are investigating senior GlaxoSmithKline staff in China for suspected "economic crimes" but it is unclear if there is any connection between the probes.
"There always has been a lot of pressure to make sure that common drugs are available at very cheap prices relative to what they would be sold for in a lot of Western markets," said Ben Cavender of the China Market Research Group consultancy.
The National Development and Reform Commission will send teams to check wholesale prices and production costs at dozens of companies.
It said the companies include Sino-foreign joint ventures with Britain's GlaxoSmithKline, Germany's Boehringer-Ingelheim and global health care firm MSD.
The inquiry will also look at Chinese companies, among them industry leader Sinopharm Group and Jiangsu Hengrui Medicine.
Police are investigating senior GlaxoSmithKline staff in China for suspected "economic crimes" but it is unclear if there is any connection between the probes.
"There always has been a lot of pressure to make sure that common drugs are available at very cheap prices relative to what they would be sold for in a lot of Western markets," said Ben Cavender of the China Market Research Group consultancy.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.